Elanco Animal Health Inc (ELAN)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 500M 1B 1.5B Q3 '21: 1.1B Q4 '21: 1.1B Q1 '22: 1.2B Q2 '22: 1.2B Q3 '22: 1B Q4 '22: 985M Q1 '23: 1.3B Q2 '23: 1.1B Q3 '23: 1.1B Q4 '23: 1B Q1 '24: 1.2B Q2 '24: 1.2B Q3 '24: 1B Q4 '24: 1B Q1 '25: 1.2B Q2 '25: 1.2B Q3 '25: 1.1B Q4 '25: 1.1B Q1 '26: 1.4B Q2 '26: 1.4B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 300M 600M 900M Q1 '24: 690M Q2 '24: 689M Q3 '24: 538M Q4 '24: 519M Q1 '25: 684M Q2 '25: 713M Q3 '25: 607M Q4 '25: 589M Q1 '26: 785M Q2 '26: 798M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Income Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Net Income Quarterly

-1.2B -800M -400M 0 400M 800M 1.2B Q3 '21: -104M Q4 '21: -105M Q1 '22: 51M Q2 '22: -10M Q3 '22: -65M Q4 '22: -54M Q1 '23: 103M Q2 '23: -97M Q3 '23: -1.1B Q4 '23: -141M Q1 '24: 32M Q2 '24: -50M Q3 '24: 364M Q4 '24: -8M Q1 '25: 67M Q2 '25: 11M Q3 '25: -34M Q4 '25: -276M Q1 '26: 57M Q2 '26: 54M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 200M 400M 600M Q3 '21: 502M Q4 '21: 510M Q1 '22: 509M Q2 '22: 484M Q3 '22: 472M Q4 '22: 448M Q1 '23: 494M Q2 '23: 434M Q3 '23: 487M Q4 '23: 516M Q1 '24: 515M Q2 '24: 495M Q3 '24: 492M Q4 '24: 501M Q1 '25: 509M Q2 '25: 528M Q3 '25: 530M Q4 '25: 555M Q1 '26: 586M Q2 '26: 570M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-150M 0 150M 300M 450M Q3 '21: 89M Q4 '21: 223M Q1 '22: -62M Q2 '22: 312M Q3 '22: 189M Q4 '22: 13M Q1 '23: -145M Q2 '23: 61M Q3 '23: 198M Q4 '23: 157M Q1 '24: 2M Q2 '24: 200M Q3 '24: 162M Q4 '24: 177M Q1 '25: -4M Q2 '25: 237M Q3 '25: 219M Q4 '25: 108M Q1 '26: 13M Q2 '26: 277M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-200M -100M 0 100M 200M 300M Q3 '21: 64M Q4 '21: 124M Q1 '22: -81M Q2 '22: 286M Q3 '22: 163M Q4 '22: -87M Q1 '23: -169M Q2 '23: 19M Q3 '23: 165M Q4 '23: 116M Q1 '24: -22M Q2 '24: 166M Q3 '24: 120M Q4 '24: 130M Q1 '25: -69M Q2 '25: 180M Q3 '25: 127M Q4 '25: 46M Q1 '26: -38M Q2 '26: 244M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 200M 400M 600M Q2 '20: 413.2M Q3 '20: 462.4M Q1 '21: 486.7M Q2 '21: 487.3M Q3 '21: 487.3M Q4 '21: 487.4M Q1 '22: 492.2M Q2 '22: 488.4M Q3 '22: 488.4M Q1 '23: 492.8M Q2 '23: 492.6M Q3 '23: 492.7M Q1 '24: 496M Q2 '24: 494.2M Q3 '24: 497.7M Q1 '25: 499.1M Q2 '25: 500.1M Q3 '25: 496.8M Q1 '26: 506M Q2 '26: 505.9M Q3 '20 Q3 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-3.00 -2.00 -1.00 0.00 1.00 2.00 3.00 Q3 '21: -1.50 Q4 '21: -0.98 Q1 '22: -0.76 Q2 '22: -0.35 Q3 '22: -0.27 Q4 '22: -0.16 Q1 '23: -0.05 Q2 '23: -0.23 Q3 '23: -2.32 Q4 '23: -2.50 Q1 '24: -2.65 Q2 '24: -2.55 Q3 '24: 0.40 Q4 '24: 0.67 Q1 '25: 0.74 Q2 '25: 0.86 Q3 '25: 0.06 Q4 '25: -0.48 Q1 '26: -0.50 Q2 '26: -0.41 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.